Evidence map›Paper›PMID 42444986›Full record

SynthesisFrontiers in aging neuroscience2026

Social cognition in Parkinson's disease: a comprehensive systematic review and integrative conceptual framework.

Maor Yeshua, Elise Klein, Martin Südmeyer, Liane Kaufmann

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maor YeshuaDepartment of Neurology and Clinical Neuropsychology, Klinikum Ernst von Bergmann, Potsdam, Germany.
Elise KleinLaPsyDÉ, UMR CNRS 8240, Université Paris Cité, Paris, France.
Martin SüdmeyerDepartment of Neurology and Clinical Neuropsychology, Klinikum Ernst von Bergmann, Potsdam, Germany.
Liane KaufmannDepartment of Neurology and Clinical Neuropsychology, Klinikum Ernst von Bergmann, Potsdam, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Parkinson's disease (PD) is characterized not only by motor symptoms but also by non-motor impairments, including deficits in social cognition (SC), defined as the ability to recognize, interpret, and respond to others' emotions, intentions, and behaviors. This systematic review synthesizes evidence on SC in PD, focusing on three core aspects: emotion recognition, empathy/Theory of Mind (ToM), and social problem-solving. Methods: We included 191 behavioral and neuroimaging studies based on a PRISMA-guided search of four databases. Results: The literature review findings revealed relatively consistent impairments in the recognition of negative emotions, such as fear and anger, and heterogeneous findings for empathy/ToM, with deficits being more pronounced in advanced PD or in patients with mild cognitive impairment (MCI). Social problem-solving remains understudied, though emerging evidence links it to dopaminergic modulation. Discussion: Across all three aspects, methodological heterogeneity and the scarcity of neuroimaging studies addressing complex SC aspects underscore the need for standardized, multimodal research. Beyond synthesizing the literature, we propose an integrative neurofunctional model of SC in PD that emphasizes its componential nature and highlights the need for future studies to clarify interrelations among SC domains and their neural substrates.

Indexed as

emotion recognitionneuroimagingParkinson’s diseasesocial cognitionsocial problem-solvingTheory of Mind (ToM)

Identifiers

PMID42444986
PMCPMC13357429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.